Millennium, Roche other research news

MLNM and Roche announced that an assay based on a novel obesity gene, OB7, will enter high throughput screening at Roche in the next few weeks to identify obesity drug candidates. This is the first gene-based drug discovery effort at MLNM to reach the screening stage. MLNM will receive a modest milestone payment when screening begins. ...